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Hl and core histone mRNA levels have been examined inthe presence of portein synthesis nhibitors with 
different mechanisms of action. Total HeLa cell RNAs were analyzed by Northern Blot hybridization 
using cloned human histone genes as probes. Inhibition of DNA replication resulted in a rapid decline in 
histone mRNA levels. However, in the presence of cycloheximide orpuromycin, Hl and core mRNAs did 
not decrease in parallel with DNA synthesis, but were stabilized and accumulated. Inhibition of DNA 
synthesis with hydroxyurea fter the inhibition of protein synthesis did not lead to a decline in histone 
mRNA levels. These results uggest that synthesis of a protein(s) - perhaps a histone protein(s) - is 
required for the coordination of DNA synthesis and histone mRNA levels. 
Hzstone mRNA DNA repbcatron Histone gene 
1. INTRODUCTION 
Many studies [l-9] have shown the close coor- 
dination of DNA replication and histone gene ex- 
pression, but the molecular basis for this relation- 
ship is not yet known. In addition to the temporal 
coupling of histone synthesis, DNA replication 
and cellular levels of histone mRNAs, it has been 
well documented in numerous biological systems 
that inhibition of DNA replication results in a 
rapid decline in the cellular representation of 
histone mRNAs. 
A requirement for protein synthesis for the 
selective destabilization of histone mRNA was in- 
itially suggested by studies [4] which showed that 
treatment of cells with cycloheximide prevented 
the cellular loss of 7-9 S RNAs (histone-enriched 
RNA fraction) which followed inhibition of DNA 
synthesis. We have recently confirmed this obser- 
vation in HeLa S3 cells by using homologous 
cloned histone gene probes to establish that cyclo- 
heximide blocks the hydroxyurea-mediated destab- 
ilization of core and Hl histone mRNAs in human 
Protem syntheses Cell cycle Polysome 
cells [lo]. A critical point for evaluating the mole- 
cular implications of these results is to determine 
whether protein synthesis per se is required for the 
cellular loss of histone mRNAs which occurs in 
conjunction with DNA synthesis inhibition, or if 
the cycloheximide-induced retention of nascent 
histone polypeptides on polysomes is prerequisite. 
We have therefore compared protein synthesis in- 
hibitors with different mechanisms of action. Our 
data suggest that destabilization of histone 
mRNAs in response to DNA synthesis inhibition is 
prevented when protein synthesis is inhibited either 
by cycloheximide or puromycin - the latter caus- 
ing a release of nascent polypeptides. The implica- 
tions of these results for autogenous control of 
cellular levels of histone mRNAs are discussed. 
2. MATERIALS AND METHODS 
[methyl-‘H]Thymidine (20.0 Ci/mmol, L-[4,5- 
3H]leucine (60 Ci/mmol) and [cy-32P]dCTP (ap- 
prox. 3000 CVmmol) were purchased from New 
England Nuclear. Hydroxyurea and puromycin 
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were from Sigma. Cycloheximide was provided by 
Upjohn Co. 
HeLa S3 cells were grown in suspension culture 
at 37°C and were maintained in exponential 
growth (2.5-5 x lo5 cells/ml). 
Relative rates of DNA or protein synthesis in the 
presence or absence of metabolic inhibitors were 
monitored by incorporation of [‘Hlthymidine or 
[3H]leucine (1 &i/ml), respectively, into tri- 
chloroacetic acid-precipitable material [ 10% (w/v) 
trichloroacetic acid for DNA, 20% for protein]. 
Labelling was initiated at various times following 
the addition of the inhibitor to 2 ml of exponen- 
tially growing HeLa cells (5 x lo5 cells/ml) and 
continued for 20 min at 37°C. Trichloroacetic 
acid-precipitable material was collected on 
0.45 pm nitrocellulose filters (Millipore type HA). 
The filters were dissolved in 1 ml ethylene glycol 
monoethyl ether (cellosolve) and the radioactivity 
was measured by liquid scintillation spectrometry 
after the addition of 10 ml cellosolve scintillation 
cocktail [ 111. 
Exponentially growing cells were divided into 7 
sets and treated as follows: (1) no inhibitors were 
added (control); (2) 1 mM hydroxyurea; (3) 1 mM 
hydroxyurea followed by the addition of cyclohex- 
imide to 0.04 mM after 10 min; (4) 0.04 mM 
cycloheximide; (5) 0.04 mM cycloheximide follow- 
ed by the addition of 1 mM hydroxyurea after 
5 min; (6) 0.4 mM puromycin; (7) 0.4 mM 
puromycin 10 min prior to treatment with 1 mM 
- 
hydroxyurea. Total cellular RNA [S] was extracted 
and subsequently analyzed for histone mRNA con- 
tent by electrophoretic fractionation under 
denaturing conditions in 1.5% (w/v) agarose-6% 
(w/v) formaldehyde gels [12] and Northern blot 
hybridization [ 131. Prehybridization, hybridiza- 
tion, and washes were carried out as in [8], except 
that prehybridization and hybridization were car- 
ried out at 42°C for Hl histone mRNA and at 
50°C for core histone mRNAs. The filters were ex- 
posed to preflashed Kodak XAR X-ray film at 
- 70°C. Hybridization was quantitated by den- 
sitometry of the autoradiograms and/or liquid 
scintillation spectrometry of the bands cut from 
the nitrocellulose filters. 
The isolation and characterization of the ACh4A 
recombinant phage containing human histone 
genes have been described [14,15]. Genomic 
restriction fragments were subcloned into pBR322 
[16]; the hybrid plasmids contained Hl (pFN C16), 
H2A + H2B (pFF 435B), H3 (pFF 435C), and H4 
(pF0 108A). Plasmid DNAs were radiolabelled by 
nick translation as in [17] using [ct-‘*P]dCTP 
(2.0-5.6 x lo8 cpm/pg). 
3. RESULTS 
The rate of DNA synthesis in control cells or 
cells in the presence of hydroxyurea, cyclohex- 
imide, or puromycin was monitored by [3H]thy- 
midine uptake. Within 25 min DNA synthesis de- 
Fig.1. (a) Relative amounts of core (0) and Hl (*) histone mRNA levels, 13H]leucme incorporation (m) and 
[3H]thymidine incorporation (A) after treatment of HeLa cells with 1 mM hydroxyurea. The points represent he 
average of 6 separate hybridizations. The autoradiogram is a representative Northern blot hybridized with pFF435B 
(H2A + H2B) and pFO108A (H4). (b) Relative amounts of [3H]leucine mcorporation (m), core histone mRNA levels 
(0) and Hl mRNA levels (*) after treatment of HeLa cells with 0.04 mM cycloheximide. Shown is the average of 6 
separate hybridizations. A representative autoradrogram shows hybridization with pFF435B (H2A + H2B) and 
pF0108A (H4). (c) Relative amounts of core (0) and Hl (*) histone mRNA levels and [‘Hlleucine uptake (H) after 
treatment of HeLa cells with 0.4 mM puromycm. A representative autoradrogram shows total cellular RNA from 
control cells and cells treated with 0.4 mM puromycin hybridized to pFNC16 (Hl) and pFF435B (H3). Hybridization 
of pFNC16 to 7 S RNA reflects annealing to a repetitive DNA sequence within the cloned fragment contammg the 
human Hl hrstone gene. The 7 S RNA species does not vary in its representation during the cell cycle, nor is its level 
influenced by inhibition of DNA replication [22]. (d) Relative amounts of core histone mRNA levels after serial 
treatment with cyclohexrmide (0) or puromycin (0) and hydroxyurea (added at the time indicated by the arrow). A 
representative autoradiogram shows hybridization with pFF435B (H2A + H2B) and pF0108A (H4) after treatment with 
puromycin and hydroxyurea. (e) Relative amounts of 13H]thynndme incorporation (A), core histone mRNA levels (0) 
and Hl htstone mRNA levels (*) after sequential treatment with hydroxyurea and cycloheximrde (added at time 
Indicated by arrow). The autoradiogram shows a representative Northern blot hybridtzed to pFNC16 (Hl) and pFF435C 
(H3). 
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creased to 5% of control levels in the cells treated 
with hydroxyurea (fig.la) or puromycin and to 
15% of control levels with cycloheximide. The 
relative rates of protein synthesis as determined by 
[3H]leucine uptake were 15% of control level after 
10 min in the presence of cycloheximide (fig.lb) 
and 8% after 10 min in the presence of puromycin 
(fig.Ic). Protein synthesis remained at 80% of the 
control levels for at least 90 min in the presence of 
hydroxyurea (fig.la). The residual 13H]leucine up- 
take detected in the presence of puromycin or 
cycloheximide may in part represent charged 
tRNAs. 
Previous work by several groups [4-6,8,10, 
l&20] has shown that inhibition of DNA syn- 
thesis leads to a rapid decrease in cellular histone 
mRNA content to a low, basal level. This apparent 
destabilization of histone mRNA was confirmed in 
the present studies, which show that cellular levels 
of core histone mRNAs were reduced to 15% of 
control after 40 min in the presence of hydrox- 
yurea. DNA synthesis inhibition resulted in a 
similar decline in the cellular representation of Hl 
histone mRNAs, with 17% of the control levels 
observed after 40 min of treatment (fig.la). 
When cehs were treated with protein synthesis 
inhibitors alone (cycloheximide or puromycin), 
there was an accumulation of both core and Hl 
histone mRNAs, despite the observed inhibition of 
DNA synthesis, with histone mRNA levels show- 
ing an approx. 2-fold increase over controls after 
100 min (fig.Ib,c). Although their mechanisms of 
action differ, there are no apparent differences in 
the effects of cycloheximide and puromycin on 
histone mRNA levels. Cellular levels of Hl and 
core mRNAs appear to be similarly affected 
(fig. 1 b). When hydroxyurea was added after addi- 
tion of protein synthesis inhibitors, both core and 
Hl histone mRNAs remained at or above control 
levels (fig.ld). In contrast, when DNA synthesis 
was inhibited prior to inhibition of protein syn- 
thesis, there was an initial decrease in both core 
and Hl histone mRNA levels to approx. 20% of 
that observed in the untreated controls. However, 
by 100 min there was an increased cellular level of 
histone mRNAs (fig.le) which appeared to be 
more pronounced for core (50% of control) than 
for Hl species (30% of controls). 
4. DISCUSSION 
We have used two different inhibitors of protein 
synthesis, cyclohe~mide and puromycin, to in- 
vestigate the mechanism by which histone gene ex- 
pression and DNA replication are functionally 
coupled. Cycloheximide inhibits the translocation 
of ribosomes resulting in the stabilization of the 
polysomal complex. Puromycin, however, is an 
aminoacyl-tRNA analog which results in early 
release of nascent polypeptides from the 
polysomes. Our results indicate that both in- 
hibitors prevent the destabilization of human 
histone mRNAs which occurs in conjunction with 
inhibition of DNA synthesis. We therefore con- 
clude that it is the inhibition of protein synthesis 
rather than an effect of a particular protein syn- 
thesis inhibitor which results in histone mRNA 
stabilization, even though blocking protein syn- 
thesis inhibits DNA replication. These results are 
in agreement with a recent report [21] that core 
histone mRNA degradation is prevented by several 
protein synthesis inhibitors and extend the obser- 
vations to include human HI mRNAs. 
If DNA replication is blocked in cells pretreated 
with a protein synthesis inhibitor, cellular levels of 
histone mRNAs are not reduced below that of un- 
treated controls; i.e., the stability of the histone 
mRNAs is not altered. Hydroxyurea may inhibit 
further histone gene transcription but does not af- 
fect the increased histone mRNA half-life 
associated with protein synthesis inhibition. Our 
experiments in which protein synthesis was in- 
hibited following inhibition of DNA replication 
suggest that once the process of histone mRNA 
destabilization has been initiated it is not readily 
reversible. 
These findings, together with our previous 
results which indicate that histone mRNA 
destabilization does not require transcription [lo], 
suggest that a post-transcriptional process is 
necessary for the coordinate and selective 
destabilization of histone mRNAs which occurs 
when DNA synthesis is inhibited. It is reasonable 
to postulate that the translation of the histone pro- 
teins is required for autogenous regulation of 
cellular histone mRNA levels. Alternatively, the 
synthesis of some other regulatory protein may be 
required as part of the feedback mechanism pro- 
viding a functional coupling of DNA replication 
and histone protein synthesis. 
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